Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp (OTCQX: TCNNF) will hold a conference call on February 26, 2026 at 8:30 AM ET to discuss its fourth quarter and full year 2025 financial results. CEO Kim Rivers and CFO Jan Reese will review financial and operating results via dial-in and live webcast.
Dial-in numbers and passcode are provided, and a replay will be archived at the company investor events page.
Trulieve (OTCQX: TCNNF) closed a second tranche of a private placement of 10.5% senior secured notes due 2030 for US$60.0 million, bringing aggregate issuance to US$200.0 million. Notes were issued at US$1,000 plus accrued interest of US$12.37 per US$1,000.
The offering was conducted on a best-efforts basis with Canaccord Genuity as sole agent and bookrunner. The company intends to use net proceeds for capital expenditures and general corporate purposes and will apply to list the Notes on the Canadian Securities Exchange after the four-month hold period.
Trulieve (OTCQX: TCNNF) announced it will open a new medical cannabis dispensary in Fort Myers, Florida, with a grand opening on January 30, 2026. Trulieve Fort Myers Beach at 17274 San Carlos Boulevard will offer walk-in and express pickup, home delivery across Florida, and retail hours of 9:00 a.m.–8:45 p.m. Monday–Saturday and 10:00 a.m.–8:00 p.m. Sunday. The location will stock Trulieve in-house brands and partner brands exclusive to Trulieve in Florida. Veterans receive 20% off and first-time guests are eligible for a 60% new customer discount.
Trulieve (OTCQX: TCNNF) applauded the Trump Administration decision on Dec 18, 2025 to reclassify marijuana to Schedule III under the Controlled Substances Act.
The company says rescheduling does not legalize marijuana but will ease federal research barriers, and — because Section 280E applies only to Schedule I/II — could remove the punitive 280E tax burden
Trulieve (OTCQX: TCNNF) closed a US$140.0 million private placement of 10.5% Senior Secured Notes due December 17, 2030. The Notes were issued at 100% of face value, bear interest at 10.5% per annum payable semi-annually, and are senior secured obligations. The offering size was increased due to market demand and was completed on a best-efforts basis with Canaccord Genuity as sole agent and bookrunner.
The company intends to use net proceeds for capital expenditures and general corporate purposes. The Notes may be redeemed in whole or in part on or after December 17, 2027. The company has applied to list the Notes on the Canadian Securities Exchange following the four-month hold period.
Trulieve (OTCQX: TCNNF) announced a new Trulieve-branded dispensary opening in Findlay, Ohio on December 19, 2025, operated by Harvest Grows LLC under a licensing agreement.
The store at 1501 W Main Cross Street will be open 8 a.m.–9 p.m. daily and offer walk-in and express pickup, promotional grand opening specials, and Trulieve products including Modern Flower and R.O. brands across multiple form factors.
Harvest Grows currently operates two other Trulieve-branded Ohio locations (Cincinnati and Lorain), and Trulieve operates several owned Ohio dispensaries listed in the announcement.
Trulieve (OTCQX: TCNNF) has received commitments for a US$100.0 million private placement of 10.5% Senior Secured Notes due December 17, 2030 to be issued at 100% of face value. Interest will be payable semi-annually and notes may be redeemed in whole or in part starting two years after issue.
The offering is on a best-efforts basis with Canaccord Genuity Corp. as sole agent and is expected to close on December 17, 2025, subject to customary conditions and CSE approval. Net proceeds are earmarked for capital expenditures and general corporate purposes. The notes will be privately offered to qualified institutional and accredited investors and will be listed on the CSE after the four-month Canadian hold period.
Trulieve (OTCQX: TCNNF) completed the redemption of all outstanding US$368,000,000 principal amount of its 8.0% senior secured notes due 2026 on December 5, 2025.
Cash used for the redemption was approximately US$373 million, which included principal plus accrued and unpaid interest to, but excluding, the redemption date. The redeemed notes ceased trading and were delisted from the Canadian Securities Exchange as of the close of trading on December 5, 2025. Additional details are available from Odyssey Trust Company.
Trulieve (OTCQX: TCNNF) announced on Dec 3, 2025 that the Texas Department of Public Safety granted conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program.
If finalized, Trulieve TX will be authorized to cultivate, manufacture, and distribute medical cannabis in Texas, expanding patient access. The license remains subject to final approval by the Texas Department of Public Safety and standard regulatory completion steps.
Trulieve (OTCQX: TCNNF) reported Q3 2025 revenue of $288 million with a 59% gross margin and GAAP gross profit of $170 million. The company recorded a net loss attributable to common shareholders of $27 million and an adjusted EBITDA of $103 million (36% of revenue). Cash flow highlights include Q3 operating cash flow of $77 million, year-to-date cash flow from operations of $214 million, and year-to-date free cash flow of $173 million. Cash at quarter end was $458 million. Trulieve operates 232 retail dispensaries, reached 820,000 rewards members, and announced a planned redemption of $368 million of senior secured notes due 2026.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
